Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Colman

Showing results (321-330 of 466) with videos related to

Pageof 47
Sort By:
Circulation Research|March 1, 1979
Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypassV P Addonizio, E J Macarak, S Niewiarowski, et al.
The Journal of Biological Chemistry|August 10, 1981
Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposureW R Figures, S Niewiarowski, T A Morinelli, et al.
The Journal of Biological Chemistry|September 25, 1992
Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studiesM Samuel, R A Pixley, M A Villanueva, et al.
The Journal of Clinical Investigation|May 1, 1988
Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulationY T Wachtfogel, W Abrams, U Kucich, et al.
The American Journal of Physiology|June 11, 1977
Function of human platelets during extracorporeal circulationV L Hennessy, R E Hicks, S Niewiarowski, et al.
The Journal of Clinical Investigation|November 1, 1988
Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factorP Chien, R A Pixley, L G Stumpo, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1992
Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active siteP G Grant, D L DeCamp, J M Bailey, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1976
Halofenate: a potent inhibitor of normal and hypersensitive plateletsR W Colman, J S Bennett, J F Sheridan, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factorM E Webster, J A Guimaraes, A P Kaplan, et al.
Clinical Reviews in Allergy & Immunology|February 2, 1999
The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitisR W Colman, R B Sartor, A A Adam, et al.
Pageof 47

Showing results (321-330 of 466) with videos related to

Sort By:
Pageof 47
Circulation Research|March 1, 1979
Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypassV P Addonizio, E J Macarak, S Niewiarowski, et al.
The Journal of Biological Chemistry|August 10, 1981
Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposureW R Figures, S Niewiarowski, T A Morinelli, et al.
The Journal of Biological Chemistry|September 25, 1992
Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studiesM Samuel, R A Pixley, M A Villanueva, et al.
The Journal of Clinical Investigation|May 1, 1988
Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulationY T Wachtfogel, W Abrams, U Kucich, et al.
The American Journal of Physiology|June 11, 1977
Function of human platelets during extracorporeal circulationV L Hennessy, R E Hicks, S Niewiarowski, et al.
The Journal of Clinical Investigation|November 1, 1988
Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factorP Chien, R A Pixley, L G Stumpo, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1992
Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active siteP G Grant, D L DeCamp, J M Bailey, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1976
Halofenate: a potent inhibitor of normal and hypersensitive plateletsR W Colman, J S Bennett, J F Sheridan, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factorM E Webster, J A Guimaraes, A P Kaplan, et al.
Clinical Reviews in Allergy & Immunology|February 2, 1999
The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitisR W Colman, R B Sartor, A A Adam, et al.
Pageof 47